Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Quarterly Revenue and Profitability Performance
IDXX logo

IDEXX Revenue Surges 14.3% as Companion Animal Diagnostics Drive $1.14 Billion Quarter

IDXX10-QFiling Date: 5/5/2026
IDEXX Laboratories, Inc.
Description

What this story covers

IDEXX Laboratories achieved 14.3% revenue growth, reaching $1.14 billion, fueled by a 19.7% surge in vet lab consumables. Despite inflationary pressures and geopolitical logistics challenges, the company maintained strong 63.4% gross margins and robust cash generation.

Story snapshot

CompanyIDEXX Laboratories, Inc.
TickerIDXX
VariantStandard detailed
Duration11:33
Filing type10-Q
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0000874716-26-000076
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-QView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in